CPHI [CHINA PHARMAS,] 10-Q/A: FORM 10-Q/A Amendment No.1 (Mark One) x September

[FORM 10-Q/A Amendment No.1 (Mark One) x September 30, 2011 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this Amendment No. 1 to Quarterly Report on Form 10-Q/A for the fiscal quarter ended September 30, 2011 of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this Amendment No. 1 to Quarterly Report on Form 10-Q/A for the fiscal quarter ended September 30, 2011of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: March 6, 2012 -------------------------------- President and Chief Executive Officer EX-32.1 4 cphi10qaex321093011.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: March 6, 2012 --------------------- (principal financial officer and principal accounting officer) EX-32.2 5 cphi10qaex322093011.htm]

By | 2016-03-03T17:59:34+00:00 March 6th, 2012|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 10-Q/A: (Original Filing)

[FORM 10-Q/A Amendment No.1 (Mark One) x September 30, 2011 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Delaware 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this Amendment No. 1 to Quarterly Report on Form 10-Q/A for the fiscal quarter ended September 30, 2011 of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this Amendment No. 1 to Quarterly Report on Form 10-Q/A for the fiscal quarter ended September 30, 2011of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:March 6, 2012 -------------------------------- President and Chief Executive Officer cphi10qaex321093011.htm 4 EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:March 6, 2012 --------------------- (principal financial officer and principal accounting officer) cphi10qaex322093011.htm 5 EX-32.2]

By | 2016-02-07T22:08:05+00:00 March 6th, 2012|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 10-Q/A: FORM 10-Q/A Amendment No.1 (Mark One) x September

[FORM 10-Q/A Amendment No.1 (Mark One) x September 30, 2011 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Delaware 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this Amendment No. 1 to Quarterly Report on Form 10-Q/A for the fiscal quarter ended September 30, 2011 of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this Amendment No. 1 to Quarterly Report on Form 10-Q/A for the fiscal quarter ended September 30, 2011of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:March 6, 2012 -------------------------------- President and Chief Executive Officer cphi10qaex321093011.htm 4 EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:March 6, 2012 --------------------- (principal financial officer and principal accounting officer) cphi10qaex322093011.htm 5 EX-32.2]

By | 2016-02-07T22:08:39+00:00 March 6th, 2012|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] CORRESP: (Original Filing)

[China Pharmas, Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 March 6, 2012 VIA EDGAR Division ofrporation Finance 100 F Street, NE Mail Stop: 3561 Attention:Jim B. Rosenberg, Seniorsistant Chief Accountant Re: China Pharmas, Form 10-K for the Fiscal Year Ended December 31, 2010]

By | 2016-02-07T22:10:00+00:00 March 6th, 2012|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] CORRESP: China Pharmas, Second Floor, No. 17, Jinpan Road

[China Pharmas, Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 March 6, 2012 VIA EDGAR Division ofrporation Finance 100 F Street, NE Mail Stop: 3561 Attention:Jim B. Rosenberg, Seniorsistant Chief Accountant Re: China Pharmas, Form 10-K for the Fiscal Year Ended December 31, 2010]

By | 2016-02-07T22:10:31+00:00 March 6th, 2012|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: (Original Filing)

[--------------- FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): February 28, 2012 CHINA PHARMA HOLDINGS, INC. ----------------------------------------------- Delaware 001-34471 73-1564807 (State or other jurisdiction (IRS Employer of Incorporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86-898-6681-1730 (China) o o o o]

By | 2016-03-03T18:04:16+00:00 March 2nd, 2012|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: ————— FORM 8-K CURRENT REPORT Date of Report

[--------------- FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): February 28, 2012 CHINA PHARMA HOLDINGS, INC. ----------------------------------------------- Delaware 001-34471 73-1564807 (State or other jurisdiction (IRS Employer of Incorporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86-898-6681-1730 (China) o o o o]

By | 2016-03-03T18:05:10+00:00 March 2nd, 2012|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: (Original Filing)

[--------------- FORM 8-K CURRENT REPORTte of Report (Date of earliest event reported): February 28, 2012 CHINA PHARMAS, ----------------------------------------------- Delaware 001-34471 73-1564807 (State or other jurisdiction (IRS Employer oforporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86-898-6681-1730 (China) o o o o Item 4.02]

By | 2016-02-07T22:11:30+00:00 March 2nd, 2012|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: ————— FORM 8-K CURRENT REPORTte of Report (Date

[--------------- FORM 8-K CURRENT REPORTte of Report (Date of earliest event reported): February 28, 2012 CHINA PHARMAS, ----------------------------------------------- Delaware 001-34471 73-1564807 (State or other jurisdiction (IRS Employer oforporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86-898-6681-1730 (China) o o o o Item 4.02]

By | 2016-02-07T22:12:21+00:00 March 2nd, 2012|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] CORRESP: (Original Filing)

[China Pharma Holdings, Inc. Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 February 28, 2012 VIA EDGAR Division of Corporation Finance 100 F Street, NE Mail Stop: 3561 Attention: Jim B. Rosenberg, Senior Assistant Chief Accountant Re: China Pharma Holdings, Inc. Form 10-K for the Fiscal Year Ended December 31, 2010 Filed March 3, 2011 and Amended]

By | 2016-03-03T18:06:14+00:00 February 28th, 2012|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar